30.07
price down icon1.57%   -0.48
after-market After Hours: 29.50 -0.57 -1.90%
loading
Structure Therapeutics Inc Adr stock is traded at $30.07, with a volume of 796.66K. It is down -1.57% in the last 24 hours and up +43.94% over the past month. Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
See More
Previous Close:
$30.55
Open:
$30.77
24h Volume:
796.66K
Relative Volume:
0.79
Market Cap:
$1.73B
Revenue:
-
Net Income/Loss:
$-100.44M
P/E Ratio:
-13.55
EPS:
-2.22
Net Cash Flow:
$-105.32M
1W Performance:
+10.23%
1M Performance:
+43.94%
6M Performance:
+99.80%
1Y Performance:
-22.62%
1-Day Range:
Value
$29.38
$30.93
1-Week Range:
Value
$27.45
$30.93
52-Week Range:
Value
$13.22
$42.57

Structure Therapeutics Inc Adr Stock (GPCR) Company Profile

Name
Name
Structure Therapeutics Inc Adr
Name
Phone
(628) 229-9277
Name
Address
611 GATEWAY BLVD SUITE 223, SOUTH SAN FRANCISCO
Name
Employee
183
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
GPCR's Discussions on Twitter

Compare GPCR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GPCR
Structure Therapeutics Inc Adr
30.07 1.76B 0 -100.44M -105.32M -2.22
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Structure Therapeutics Inc Adr Stock (GPCR) Upgrades & Downgrades

Date Action Analyst Rating Change
May-02-25 Initiated Citigroup Buy
Feb-28-25 Initiated William Blair Outperform
Jan-08-25 Initiated Stifel Buy
Dec-04-24 Initiated H.C. Wainwright Buy
Sep-23-24 Initiated Morgan Stanley Overweight
May-21-24 Initiated JP Morgan Overweight
Apr-09-24 Initiated Cantor Fitzgerald Overweight
Oct-19-23 Initiated JMP Securities Mkt Outperform
Jul-27-23 Initiated Piper Sandler Overweight
May-25-23 Resumed Jefferies Buy
Feb-28-23 Initiated BMO Capital Markets Outperform
Feb-28-23 Initiated Guggenheim Buy
Feb-28-23 Initiated Jefferies Buy
Feb-28-23 Initiated SVB Securities Outperform
View All

Structure Therapeutics Inc Adr Stock (GPCR) Latest News

pulisher
Oct 11, 2025

Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 11, 2025
pulisher
Oct 09, 2025

Structure Therapeutics' (GPCR) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 04, 2025

Structure Therapeutics Inc. Sponsored ADR $GPCR Shares Purchased by Signaturefd LLC - Defense World

Oct 04, 2025
pulisher
Oct 04, 2025

Piper Sandler Keeps Their Buy Rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR) - The Globe and Mail

Oct 04, 2025
pulisher
Oct 03, 2025

Layoff Tracker: CSL Vifor, Bolt Cut Staff - BioSpace

Oct 03, 2025
pulisher
Oct 03, 2025

Citius Oncology (NASDAQ:CTOR) and Structure Therapeutics (NASDAQ:GPCR) Head to Head Survey - Defense World

Oct 03, 2025
pulisher
Oct 01, 2025

Structure Therapeutics (NASDAQ:GPCR) Trading Down 4.3%Should You Sell? - MarketBeat

Oct 01, 2025
pulisher
Oct 01, 2025

ABSSSI Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Glenmark Pharma, Melinta Therapeutics, Sandoz Inc, Paratek Pharma, AbbVie Inc., Allergan PLC, Merck & Co. Inc., Pfizer - The Globe and Mail

Oct 01, 2025
pulisher
Oct 01, 2025

ABSSSI Market to Reach New Heights in Growth by 2034, - openPR.com

Oct 01, 2025
pulisher
Sep 30, 2025

Structure Therapeutics (NASDAQ:GPCR) Trading 5.8% HigherTime to Buy? - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense - The Globe and Mail

Sep 30, 2025
pulisher
Sep 27, 2025

Banque Pictet & Cie SA Sells 11,365 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat

Sep 27, 2025
pulisher
Sep 24, 2025

Structure Therapeutics stock rating reiterated at Buy by H.C. Wainwright - Investing.com India

Sep 24, 2025
pulisher
Sep 23, 2025

Interactive Brokers Group, Inc. $IBKR Shares Acquired by Swedbank AB - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Sumitomo Mitsui DS Asset Management Company Ltd Makes New Investment in Confluent, Inc. $CFLT - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Exchange Traded Concepts LLC Buys 1,054 Shares of TKO Group Holdings, Inc. $TKO - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

IFM Investors Pty Ltd Has $3.42 Million Stock Position in Annaly Capital Management Inc $NLY - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

MongoDB, Inc. $MDB Shares Acquired by IFM Investors Pty Ltd - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Wealth Enhancement Advisory Services LLC Grows Stock Holdings in VanEck Semiconductor ETF $SMH - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Voya Investment Management LLC Buys 1,696 Shares of PriceSmart, Inc. $PSMT - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Voya Investment Management LLC Lowers Stock Position in Dutch Bros Inc. $BROS - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Vanguard Total International Bond ETF $BNDX Shares Bought by Exchange Traded Concepts LLC - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

IFM Investors Pty Ltd Boosts Position in Evergy Inc. $EVRG - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

IFM Investors Pty Ltd Grows Holdings in Trimble Inc. $TRMB - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

UnitedHealth Group Incorporated $UNH Shares Acquired by Exchange Traded Concepts LLC - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

DNOW Inc. $DNOW Shares Purchased by Exchange Traded Concepts LLC - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Exchange Traded Concepts LLC Purchases 22,809 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

IFM Investors Pty Ltd Purchases 2,676 Shares of Deckers Outdoor Corporation $DECK - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Exchange Traded Concepts LLC Has $1.14 Million Holdings in Molina Healthcare, Inc $MOH - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Exchange Traded Concepts LLC Acquires New Holdings in Vanguard Total Stock Market ETF $VTI - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Pallas Capital Advisors LLC Buys New Shares in Keysight Technologies Inc. $KEYS - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Parallel Advisors LLC Takes $171,000 Position in Structure Therapeutics Inc. Sponsored ADR $GPCR - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

BICO Group AB (publ) (OTCMKTS:CLLKF) Stock Price Down 10.2% – Should You Sell? - Defense World

Sep 23, 2025
pulisher
Sep 22, 2025

Structure Therapeutics (NASDAQ:GPCR) Shares Gap UpShould You Buy? - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Biotech Stocks Moving Premarket: QLGN, MBX, HSDT, And Other Gainers & Losers - RTTNews

Sep 22, 2025
pulisher
Sep 22, 2025

iShares U.S. Insurance ETF $IAK Shares Sold by Focus Financial Network Inc. - Defense World

Sep 22, 2025
pulisher
Sep 22, 2025

xFOREST Therapeutics and Axcelead DDP Launch Joint Research Initiative on RNA Structure-Targeted Small Molecule Drug Discovery - BioSpace

Sep 22, 2025
pulisher
Sep 21, 2025

Structure Therapeutics Inc. (GPCR) Eyes Major 2025 Catalyst With Phase 2b Obesity Data - Insider Monkey

Sep 21, 2025
pulisher
Sep 21, 2025

Relay Therapeutics, Inc. (RLAY) Shows Breakthrough Breast Cancer Results With RLY-2608 - Yahoo Finance

Sep 21, 2025
pulisher
Sep 21, 2025

Structure Therapeutics (NASDAQ:GPCR) Trading 6.3% HigherHere's What Happened - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Receives $75.71 Average Price Target from Brokerages - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Analysts Are Bullish on These Healthcare Stocks: Scholar Rock Holding (SRRK), Akero Therapeutics (AKRO) - The Globe and Mail

Sep 20, 2025
pulisher
Sep 19, 2025

Top 10 AI-Powered Biotech Stocks to Buy Now - Insider Monkey

Sep 19, 2025
pulisher
Sep 18, 2025

Promising Market Potential for Structure Therapeutics: Buy Rating Backed by Superior Trial Results and Market Opportunities - TipRanks

Sep 18, 2025
pulisher
Sep 17, 2025

Structure Therapeutics stock rating reiterated by Cantor Fitzgerald - Investing.com

Sep 17, 2025
pulisher
Sep 17, 2025

Structure Therapeutics stock rating reiterated by JMP, citing positive safety data - Investing.com

Sep 17, 2025
pulisher
Sep 16, 2025

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Gets a Buy from LifeSci Capital - The Globe and Mail

Sep 16, 2025
pulisher
Sep 15, 2025

Zimmer Partners LP Purchases 43,876 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat

Sep 15, 2025
pulisher
Sep 13, 2025

Exome Asset Management LLC Decreases Position in Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat

Sep 13, 2025
pulisher
Sep 13, 2025

Equities Analysts Set Expectations for GPCR Q3 Earnings - MarketBeat

Sep 13, 2025

Structure Therapeutics Inc Adr Stock (GPCR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Cap:     |  Volume (24h):